| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* The Walter and Eliza Hall Institute of Medical Research,
The Cooperative Research Centre for Vaccine Technology, Victoria, Melbourne, Australia; and
Department of Clinical Chemistry, University Hospital, Lund, Sweden
Dendritic cells (DC) undergo complex developmental changes during maturation. The MHC class II (MHC II) molecules of immature DC accumulate in intracellular compartments, but are expressed at high levels on the plasma membrane upon DC maturation. It has been proposed that the cysteine protease inhibitor cystatin C (CyC) plays a pivotal role in the control of this process by regulating the activity of cathepsin S, a protease involved in removal of the MHC II chaperone Ii, and hence in the formation of MHC II-peptide complexes. We show that CyC is differentially expressed by mouse DC populations. CD8+ DC, but not CD4+ or CD4-CD8- DC, synthesize CyC, which accumulates in MHC II+Lamp+ compartments. However, Ii processing and MHC II peptide loading proceeded similarly in all three DC populations. We then analyzed MHC II localization and Ag presentation in CD8+ DC, bone marrow-derived DC, and spleen-derived DC lines, from CyC-deficient mice. The absence of CyC did not affect the expression, the subcellular distribution, or the formation of peptide-loaded MHC II complexes in any of these DC types, nor the efficiency of presentation of exogenous Ags. Therefore, CyC is neither necessary nor sufficient to control MHC II expression and Ag presentation in DC. Our results also show that CyC expression can differ markedly between closely related cell types, suggesting the existence of hitherto unrecognized mechanisms of control of CyC expression.
Related articles in The JI:
This article has been cited by other articles:
|
|
 |
|
  M. Mihelic, A. Dobersek, G. Guncar, and D. Turk Inhibitory Fragment from the p41 Form of Invariant Chain Can Regulate Activity of Cysteine Cathepsins in Antigen Presentation J. Biol. Chem., May 23, 2008; 283(21): 14453 - 14460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Young, N. S. Wilson, P. Schnorrer, A. Mount, R. J. Lundie, N. L. La Gruta, B. S. Crabb, G. T. Belz, W. R. Heath, and J. A. Villadangos Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens PNAS, November 6, 2007; 104(45): 17753 - 17758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Zavasnik-Bergant, U. Repnik, A. Schweiger, R. Romih, M. Jeras, V. Turk, and J. Kos Differentiation- and maturation-dependent content, localization, and secretion of cystatin C in human dendritic cells J. Leukoc. Biol., July 1, 2005; 78(1): 122 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Naik, A. I. Proietto, N. S. Wilson, A. Dakic, P. Schnorrer, M. Fuchsberger, M. H. Lahoud, M. O'Keeffe, Q.-x. Shao, W.-f. Chen, et al. Cutting Edge: Generation of Splenic CD8+ and CD8- Dendritic Cell Equivalents in Fms-Like Tyrosine Kinase 3 Ligand Bone Marrow Cultures J. Immunol., June 1, 2005; 174(11): 6592 - 6597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nishikawa Presence of Anti-cystatin C-positive Dendritic Cells or Macrophages and Localization of Cysteine Proteases in the Apical Bud of the Enamel Organ in the Rat Incisor J. Histochem. Cytochem., May 1, 2005; 53(5): 643 - 651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Wong, L. Santambrogio, and J. L. Strominger Caspases and nitric oxide broadly regulate dendritic cell maturation and surface expression of class II MHC proteins PNAS, December 21, 2004; 101(51): 17783 - 17788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. S. Wilson, D. El-Sukkari, and J. A. Villadangos Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis Blood, March 15, 2004; 103(6): 2187 - 2195. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
